Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we currently market two commercial products, Protein A and SecreFlo®, which partially fund the advancement of our development pipeline while supporting our financial stability. ( www.repligen.com )
Repligen Corporation
41 Seyon Street Building #1, Suite 100
Waltham, Massachusetts 02453
USA
Tel: (781) 250-0111
Fax: (781) 250-0115